Nanosonics Valuation Multiples

Nanosonics Overview

About Nanosonics

Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.

Founded

2000

HQ

Employees

470

Website

nanosonics.com.au

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $143M

EBITDA: $17M

EV

$617M

Valuation Multiples

Multiples.vc

Start free trial

Nanosonics Financials

Nanosonics reported last 12-month revenue of $143M and EBITDA of $17M.

In the same LTM period, Nanosonics generated $110M in gross profit, $17M in EBITDA, and $12M in net income.

Nanosonics P&L

In the most recent fiscal year, Nanosonics reported revenue of $140M and EBITDA of $22M.

Nanosonics expects next 12-month revenue of XXX and NTM EBITDA of XXX

Nanosonics Stock Performance

Nanosonics has current market cap of $725M, and enterprise value of $617M.

Nanosonics' stock price is $2.39.

Nanosonics Valuation Multiples

Nanosonics trades at 4.3x EV/Revenue multiple, and 36.9x EV/EBITDA.

Nanosonics Financial Valuation Multiples

As of March 23, 2026, Nanosonics has market cap of $725M and EV of $617M.

Equity research analysts estimate Nanosonics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Nanosonics has a P/E ratio of 58.3x.

Nanosonics Margins & Growth Rates

Nanosonics' revenue in the last 12 month grew by 11%.

Nanosonics' revenue per employee in the last FY averaged $0.3M.

Nanosonics' rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nanosonics' rule of X is 40% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Nanosonics Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Nanosonics M&A Activity

Nanosonics acquired XXX companies to date.

Last acquisition by Nanosonics was on XXXXXXXX, XXXXX. Nanosonics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Nanosonics Investment Activity

Nanosonics invested in XXX companies to date.

Nanosonics made its latest investment on XXXXXXXX, XXXXX. Nanosonics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).